The Evolving Role of Targeted Biological Agents in the Management of Indolent B-Cell Lymphomas

Therapeutic Advances in Hematology - United States
doi 10.1177/2040620717738740
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

SAGE Publications

Related search

Copanlisib Synergies With Conventional and Targeted Agents Including Venetoclax in Preclinical Models of B- And T-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Role of C-Myc in B-Cell Lymphomas: Diagnostic and Molecular Aspects

Genes
Genetics
2017English

Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents

Current Oncology
Oncology
2009English

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas

Advances in Hematology
Hematology
2012English

In Vitro Demonstration of Synergism With Pixantrone Combined With Targeted Agents in Lymphomas

British Journal of Haematology
Hematology
2018English

Clinical Application of Total Skin Electron Beam (TSEB) Therapy for the Management of T Cell Cutaneous Lymphomas. The Evolving Role of Low Dose (12 Gy) Treatment Schedule

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Cell Cycle Deregulation in B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

The Diagnosis and Management of NK/T-cell Lymphomas

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

The Evolving Role of Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma

Hepatoma Research
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy